BRCA2 and ovarian carcinoma: Evidence of serous tubal intraepithelial carcinoma in risk-reducing salpingo-oophorectomy of asymptomatic women with known BRCA1 or BRCA2 mutations or strong family history of breast or ovarian cancer.